Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/9/2024 | $35.00 | Mkt Perform → Outperform | Barrington Research |
| 5/6/2024 | $50.00 | Hold → Buy | Lake Street |
| 2/23/2024 | $60.00 → $40.00 | Buy → Hold | Deutsche Bank |
| 2/23/2024 | $60.00 → $39.00 | Buy → Hold | Jefferies |
| 8/3/2022 | $145.00 | Overweight | Stephens |
| 2/28/2022 | $190.00 → $155.00 | Outperform | Barrington Research |
| 2/3/2022 | $180.00 → $150.00 | Buy | Deutsche Bank |
| 12/17/2021 | $180.00 | Buy | Deutsche Bank |
Barrington Research upgraded ModivCare from Mkt Perform to Outperform and set a new price target of $35.00
Lake Street upgraded ModivCare from Hold to Buy and set a new price target of $50.00
Deutsche Bank downgraded ModivCare from Buy to Hold and set a new price target of $40.00 from $60.00 previously
Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern
NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced the appointment of Jeff Bennett as Chief Strategy and Innovation Officer and Seth Ravine as Chief Commercial Officer, effective December 2023. "I am incredibly excited for the appointment of these two positions, underscoring our commitment to building a top-notch leadership team that will steer Modivcare's strategic course and drive success in this dynamic landscape," said Heath Sampson, President and CEO of Modivcare. "The addition of Jeff and Seth's roles reinfo
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Summary: Service revenue of $702.8 million, remaining consistent with the fourth quarter of 2023 Net loss of $23.5 million, or negative $1.64 per diluted common share Adjusted EBITDA(1) of $40.4 million, adjusted net income(1) of $2.7 million and adjusted EPS(1) of $0.19 per diluted common share Net cash provided by operating activities during the quarter of $30.0
Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the fourth quarter and full year ended December 31, 2024, on Thursday, March 6, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investo
DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization (CRO), today announced that it will appoint Erin L. Russell, a financial and healthcare executive, as a new independent member of the Company's Board of Directors (the "Board") effective immediately prior to the next regularly scheduled meeting of the Board. Ms. Russell is being appointed in connection with a cooperation agreement (the "Agreement") between Fortrea and Starboard Value LP (together with its affiliates, "Starboard"), an investment firm that owns approximately 5.4% of the Company's outstanding common stock. "We are pleased to have reached a constructive agree
SC 13D/A - ModivCare Inc (0001220754) (Subject)
SC 13D/A - ModivCare Inc (0001220754) (Subject)
SC 13D/A - ModivCare Inc (0001220754) (Subject)
10-K - ModivCare Inc (0001220754) (Filer)
8-K - ModivCare Inc (0001220754) (Filer)
DEFA14A - ModivCare Inc (0001220754) (Filer)
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Summary: Service revenue of $702.8 million, remaining consistent with the fourth quarter of 2023 Net loss of $23.5 million, or negative $1.64 per diluted common share Adjusted EBITDA(1) of $40.4 million, adjusted net income(1) of $2.7 million and adjusted EPS(1) of $0.19 per diluted common share Net cash provided by operating activities during the quarter of $30.0
Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the fourth quarter and full year ended December 31, 2024, on Thursday, March 6, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investo
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three and nine months ended September 30, 2024. Third Quarter 2024 Summary: Service revenue of $702.0 million increased 2.2% from the third quarter of 2023 Net loss of $26.6 million, or negative $1.87 per diluted common share Adjusted EBITDA(1) of $43.2 million, adjusted net income(1) of $6.4 million and adjusted EPS(1) of $0.45 per diluted common share Cash provided by operating activities during the quarter of $9.3 million and
3 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
3 - ModivCare Inc (0001220754) (Issuer)